People

Alain Parthoens

newtonbiocapital.com

Alain has 20 years international experience in food and biotech industry as well as 20 years in venture capital. He has been a lead investor for many investments in early and neglected late-stage companies that he then brought through to an IPO or M&A transaction, including Ogeda (sold to Astellas for EUR 800 million). Based in Belgium Newton Biocapital publicly documents this person as Chief Executive Officer; Co-founder. The affiliation is scoped to the published role, with no personal cash investment inferred.